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Clinical Summary 
A patient with menorrhagia and dysmenorrhoea underwent an MRI study which revealed an uncommon 
presentation of a very common uterine pathology. 
Clinical History and Imaging Procedures 
The patient was admitted after several episodes of menorrhagia (anaemia of 5-8g/dl), and pelvic pain. 
Two days prior to admission, a pelvic and transvaginal ultrasound was performed, which revealed a 
submucosal uterine leiomyoma. Afterwards, during admission, an MRI study was made, leading to the 
diagnosis of prolapsed submucosal uterine leiomyoma. A hysterectomy was performed. 
Discussion 
Uterine leiomyoma, the most frequent solid uterine neoplasm (accounting for approximately 30% of all 
hysterectomies performed in the US), is a benign lesion composed mainly of smooth muscle with varying 
amounts of fibrous connective tissue elements. As leiomyomas enlarge, they may outgrow their blood 
supply, resulting in various types of degeneration such as hyaline, myxoid, cystic and red degeneration. 
Uterine leiomyomas develop during the reproductive years in 20-30% of women, may grow rapidly during 
pregnancy or contraceptive use and usually regress after the menopause, which suggests an important 
role of oestrogen and progesterone in their growth.
These lesions, which may be single or multiple, are classified according to their position in the uterus as 
submucosal, intramural or subserous. Submucosal leiomyomas constitute only 5% of uterine 
leiomyomas, may be pedunculated and may prolapse from the uterine cavity. The prevalence of 
prolapsing submucosal leiomyomas was 2.5% in a population of 1785 women undergoing abdominal 
surgery for uterine leiomyomas.[1] Submucosal leiomyomas can be asymptomatic or may present with 
menorrhagia, dysmenorrhoea, infertility, pelvic pressure or as a palpable mass lesion.
Although ultrasound (specially transvaginal ultrasound) can often diagnose and characterise 
leiomyomas, MRI is the most accurate imaging technique for detection, localisation and characterisation 
of leiomyomas. In respect of submucosal leiomyomas, MRI is also better than ultrasonography in 
determining the presence of prolapse, its caudal extent and location of the stalk.
Most commonly, non-degenerated uterine leiomyomas are well-circumscribed masses of 
homogeneously decreased signal intensity compared with that of the adjacent myometrium on T1- and 
especially on T2-weighted images. On the other hand, cellular leiomyomas, which are composed mainly 
of compact smooth muscle cells, can show relatively higher signal on T2-weighted images and show 
enhancement on contrast-enhanced images. Leiomyomas appear to be delineated by a discrete low 
signal intensity margin. Sometimes a high intensity rim may be seen surrounding these lesions on T2-
weighted images, which corresponds to dilated lymphatics, dilated veins or oedema. Central or diffuse 
areas of increased signal intensity may be evident in certain types of degeneration such as in the cystic 
or myxoid types.
In addition to making an accurate diagnosis and characterisation of these lesions, MRI can assist in pre-
treatment planning by selecting the lesions which are more suitable for the different treatment modalities 
such as hysteroscopic resection (for submucosal-intramural leiomyomas) or transabdominal or 
laparoscopic myomectomy (for intramural and subserosal leiomyomas). Further, MRI can demonstrate 
post-surgical complications such as haematoma, abscess, fistula, uterine rupture and peritoneal 
inclusion cyst. MRI can also monitor for changes in size of individual lesions as well as of the uterus 
during GnRH analogue therapy. Three-dimensional contrast-enhanced MRI arteriography can show the 
uterine arteries thus providing important data when planning for leiomyoma embolisation; MRI can also 
be used after embolisation in order to demonstrate the degree of shrinkage and loss of enhancement of 
the leiomyomas. 
Final Diagnosis 
Prolapsed submucosal uterine leiomyoma 
Figures
Figure 1 
A uterine leiomyoma is evident. It seems to 
display intramural/submucous growth. 
Figure 2 
This axial T2-weighted image is at the level of 
the body of the uterus. The leiomyoma is 
partially identified as a heterogeneous, lesion 
of intermediate signal intensity inside the 
uterine cavity. 
This axial T2-weighted image is at the level of 
the uterine cervix. The leiomyoma is already 
protruding through the cervical canal. 
This sagittal T2-weighted uterine scan shows the 
leiomyoma (intermediate signal intensity, 
heterogeneous) protruding through the cervical canal. 
Cystic/myxoid degeneration is present as areas of high 
signal intensity. 
This parasagittal T2-weighted uterine scan was 
performed to the left of the previous one and clearly 
depicts the leiomyoma's stalk (white arrow). 
Figure 3 
Hysterectomy specimen shows a prolapsing leiomyoma. 
The stalk implantation point is clearly evident. 
Degeneration of the cystic/myxoid type is also seen. 
MeSH
Uterine Neoplasms
 [C04.588.945.418.948]
Tumors or cancer of the UTERUS. 
Cervix Neoplasms
 [C13.371.270.875.170]
Tumors or cancer of the uterine cervix. 
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